Partial agonists as therapeutic agents at neuronal nicotinic acetylcholine receptors
- 1 February 2007
- journal article
- review article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 73 (4) , 459-468
- https://doi.org/10.1016/j.bcp.2006.08.010
Abstract
No abstract availableKeywords
This publication has 94 references indexed in Scilit:
- Does smoking reduce akathisia? Testing a narrow version of the self-medication hypothesisSchizophrenia Research, 2006
- The neurobiological basis for partial agonist treatment of nicotine dependence: vareniclineInternational Journal Of Clinical Practice, 2006
- Protective Effect of GTS-21, a Novel Nicotinic Receptor Agonist, on Delayed Neuronal Death Induced by Ischemia in GerbilsThe Japanese Journal of Pharmacology, 1998
- The neurotoxicity of amyloid beta protein in aged primatesAmyloid, 1998
- Paradoxical allosteric effects of competitive inhibitors on neuronal α7 nicotinic receptor mutantsNeuroReport, 1997
- Epibatidine and ABT 418 reveal selective losses of α4β2 nicotinic receptors in Alzheimer brainsNeuroReport, 1995
- Chronic nicotine intake decelerates aging of nigrostriatal dopaminergic neuronsLife Sciences, 1994
- Nicotine-induced sensitization to ambulatory stimulant effect produced by daily administration into the ventral tegmental area and the nucleus accumbens in ratsLife Sciences, 1992
- On the application of “a plausible model” of allosteric proteins to the receptor for acetylcholineJournal of Theoretical Biology, 1967
- On the nature of allosteric transitions: A plausible modelJournal of Molecular Biology, 1965